2012•Unpublished venueRequires access

Is Hepatic Uric Acid Production a Potential Biomarker of Compromised Mitochondrial Function

Ishita Sinha, John L. Petrie, Ziad H. Al‐Oanzi, Catherine Arden, Loranne Agius

Open publisher page 0 citations

Abstract

Background Raised plasma uric acid levels are associated with cardiovascular disease, renal disease and metabolic syndrome. Uric acid is produced by the liver during purine metabolism and is excreted by the kidneys. Therefore raised plasma uric acid can result from either decreased renal clearance or increased production by the liver. Recent studies have shown an association between raised serum uric acid levels and hepatic steatosis in Non-Alcoholic Liver Disease (NAFLD) after adjustment for various features of metabolic syndrome (1-3) and proposed a role for uric acid in the pathogenesis of liver disease through its pro-inflammatory effects (3).

About this research paper

What this paper is about

Background Raised plasma uric acid levels are associated with cardiovascular disease, renal disease and metabolic syndrome. Uric acid is produced by the liver during purine metabolism and is excreted by the kidneys. Therefore raised plasma uric acid can result from either decreased renal clearance or increased production by the liver. Recent studies have shown an association between raised serum uric acid levels and hepatic steatosis in Non-Alcoholic Liver Disease (NAFLD) after adjustment for various features of metabolic syndrome (1-3) and proposed a role for uric acid in the pathogenesis of liver disease through its pro-inflammatory effects (3).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background Raised plasma uric acid levels are associated with cardiovascular disease, renal disease and metabolic syndrome. Uric acid is produced by the liver during purine metabolism and is excreted by the kidneys. Therefore raised plasma uric acid can result from either decreased renal clearance or increased production by the liver. Recent studies have shown an association between raised serum uric acid levels and hepatic steatosis in Non-Alcoholic Liver Disease (NAFLD) after adjustment for various features of metabolic syndrome (1-3) and proposed a role for uric acid in the pathogenesis of liver disease through its pro-inflammatory effects (3).

Key concepts: Uric acid, Internal medicine, Pathogenesis, Endocrinology, Medicine, Steatosis, Liver disease, Metabolism

Related papers

Back to paper searchBrowse research topicsOriginal source
Is Hepatic Uric Acid Production a Potential Biomarker of Compromised Mitochondrial Function — Research Paper | ScholarLens